Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2026)
Cytek Biosciences (CTKB) posted Other Working Capital Changes of -$3.9 million for Q1 2026, down 321.95% on a QoQ basis from $1.7 million in Q4 2025, and down 2685.91% year-over-year from $149000.0 in Q1 2025.
Cytek Biosciences (CTKB) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Cytek Biosciences' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$3.9 million for Q1 2026.
- Quarterly Other Working Capital Changes fell 2685.91% year-over-year to -$3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$401000.0 (down 1315.15% YoY) and the FY2025 annual result came in at $3.6 million, up 28.2% from the prior year.
- Other Working Capital Changes was -$159000.0 for Q1 2026 at Cytek Biosciences, up from -$1.1 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at -$159000.0 in Q1 2026 and bottomed at -$1.2 million in Q2 2025.
- A 4-year average of -$788900.0 and a median of -$733000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 2050.74% — and 2026, when it slumped 2685.91%.
- Cytek Biosciences' Other Working Capital Changes stood at -$739000.0 in 2023, then slumped by 54.26% to -$1.1 million in 2024, then grew by 5.35% to -$1.1 million in 2025, then surged by 85.26% to -$159000.0 in 2026.
- Business Quant data shows CTKB's Other Working Capital Changes at -$159000.0 in Q1 2026, -$1.1 million in Q3 2025, and -$1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Cytek Biosciences | 586.89 Mn | 521.19 Mn | 21.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.85 Mn |
| Mar 31, 2026 | -3.85 Mn |
| Mar 31, 2026 | -3.85 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Dec 31, 2025 | 1.74 Mn |
| Sep 30, 2025 | 284,000.00 |
| Sep 30, 2025 | 284,000.00 |
| Sep 30, 2025 | 284,000.00 |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 742,000.00 |
| Dec 31, 2024 | 742,000.00 |
| Dec 31, 2024 | 742,000.00 |
| Sep 30, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.49 Mn |